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The threat of synthetic drugs is one of the most signif-
icant drug problems worldwide. After cannabis, am-
phetamine-type stimulants (ATS) are the second most 
widely used drugs across the globe, outstripping the 
use of cocaine and heroin. Since 1990 the illicit 
manufacture of ATS has been reported from 
more than 65 countries and the figure keeps 
rising. Trends on the synthetic drug market 
evolve quickly each year. 
The UNODC Global Synthetics Monitoring: 
Analyses, Reporting and Trends (SMART) Pro-
gramme enhances the capacity of Member States in 
priority regions to generate, manage, analyse, report 
and use synthetic drug information to design effective 
policy and programme interventions. Global SMART 
was launched in September 2008 and provides ca-
pacity-building in East and South-East Asia and, since 
2011, in Latin America. Global SMART also regularly 
reviews the ATS situation in the Pacific region. Fea-
tures of UNODC Global SMART are online data col-
lection, situation reports and regional assessments. A 
review of the global ATS situation was issued 
in September 2011. The third annual review 
of patterns and trends of ATS and Other 
Drugs in Asia and the Pacific 2011 was is-
sued in November 2011, providing detailed 
data and information on 15 countries in East 
and South-East Asia, with regional coverage of 
South Asia and Oceania. 
The Global SMART Update is designed to provide reg-
ular brief reporting on emerging patterns and trends 
of the fast changing global synthetic drug situation. 
Given the speed at which changes in the ATS markets 
occur, it is especially important to have a simple sus-
tainable mechanism for frequent information sharing 
from different parts of the world. The Global SMART 
Update is published twice a year and is available in 
English and Spanish. 
The Update reports synthetic drug informa-
tion in several categories, such as significant 
or unusual drug or precursor chemical sei-
zures, new locations, methods and chemi-
cals used for clandestine manufacture, new 
trafficking groups or routes, changes in legis-
lation to address the problem of synthetic drugs, 
environmental impact from their illicit manufacture 
and destruction, emerging drugs or user groups, and 
health implications related to their use.*
Each issue of the Update contains special coverage 
and thematic segments. Since October 2010, the 
special segment of the Update has been expanded to 
provide a more in-depth review of an issue of current 
interest. In addition, short regional overviews 
have been added to provide snapshots of 
the situation in the regions of the world. 
In previous issues, the Update highlighted 
the increasing dimension of ATS trafficking 
from Africa; the situation on ATS in South 
Asia; the latest developments on synthetic 
substances which are sold in ATS markets as ‘bath 
salts’ and ‘plant food’; and the recent changes in 
illicit ATS manufacture, particularly the replacement 
of traditional precursors with alternate chemicals or 
chemically-modified forms not under international 
control.
The special segment of the current issue takes a closer 
look at new psychoactive substances (NPS) - substances 
which are not controlled under the international 
drug conventions but which have emerged 
in all regions of the world and may pose a 
risk to public health. Broad global concern 
over NPS led to the adoption of resolution 
55/1 entitled “Promoting international 
cooperation in responding to the challenges 
posed by new psychoactive substances”, at 
the 55th session of the Commission on Narcotic 
Drugs, the main United Nations drug policy-making 
body. The segment provides an overview on the 
various NPS available on illicit ATS markets and a 
critical assessment of some of the challenges posed 
by NPS to the international community. 
While data on ATS seizures is often easy to obtain, 
information about the demand for ATS remains scarce 
and anecdotal in nature. Nevertheless, the Update 
continues to make a determined effort to 
highlight the human toll of ATS use. Various 
demand-related subjects are covered in 
this issue, including facts that have come to 
light about the use of synthetic drugs and 
their impact in Argentina, Australia, Canada, 
Hungary, Japan, Spain, the United Kingdom, 
the United States, Uruguay, and Viet Nam. The 
Update also covers the results of the latest ESPAD/
EMCDDA study on substance use among students in 
various European countries.
About the SMART Update In this issue
*The information and data contained within this report are from official Government reports, press releases, scientific journals or incidents confirmed by 
UNODC Field Offices. Additional or updated information from previously reported incidents may also be included where appropriate. Information denoted 
with an asterisk (*) are from ‘open sources’ where UNODC is waiting for official confirmation and therefore should be considered only preliminary. This report 
has not been formally edited. The contents of this publication do not necessarily reflect the views or policies of UNODC or contributory organizations and 
neither do they imply any endorsement. Suggested citation: Global SMART Update Volume 8, September 2012.
Oceania. Australia and New Zealand continue to be 
significant markets for ATS, with the highest num-
ber of ATS seizures in a decade made at the Austra-
lian border. Data on the ATS situation in the Pacific 
remains sparse but lifetime prevalence of the use 
of methamphetamine is reported to be high 
among the young generation. There is also 
evidence of injecting methamphetamine 
use in many Pacific Island States and territo-
ries, for example, in Vanuatu. Ecstasy use is 
on the decline in Australia and New Zealand, 
but annual prevalence remains high at 2.9 per 
cent. 
East and South-East Asia. East and South-East Asia 
has the second biggest ATS market with metham-
phetamine seizures steadily increasing accounting 
for almost half of the global total. Illicit manufacture 
is reported from Cambodia, China, Indonesia, Japan, 
Lao PDR, Malaysia, Myanmar, Philippines, Republic 
of Korea and Thailand. Drug trafficking organizations 
from West Africa continue to target the region for 
methamphetamine smuggling activities. Diversion of 
pharmaceutical preparations containing pseu-
doephedrine are commonly observed. New 
psychoactive substances have also been re-
ported in several countries in the region and 
Japan has introduced measures against their 
sale and distribution. 
South Asia. In South Asia, there has reportedly 
been an increase in the use of ATS in Bhutan, Sri Lanka 
and in Bangladesh, where methamphetamine pills are 
widely available, especially in urban areas. South Asia 
continues to be targeted by organized crime groups as 
a source of ATS precursors, particularly ephedrine and 
pseudoephedrine. Data on ATS use and manufacture 
in the region is very sparse as no comprehensive as-
sessment on the ATS situation has ever been under-
taken. 
West Asia and the Middle East. Amphetamine, 
commonly sold as Captagon, continues to be 
the most frequently seized substance in this 
region. The region experienced a large de-
crease in amphetamine seizures from 23.8 
mt in 2009 to 13.5 mt in 2010. However, 
methamphetamine seizures have increased 
in some countries in West Asia, including 
Israel and the Islamic Republic of Iran. Some coun-
tries have high requirements of ATS precursors which 
makes them vulnerable to possible diversion of the 
chemicals to illicit channels. In Pakistan, the disap-
pearance of almost 9 mt of ephedrine is being inves-
tigated by authorities. There is an information gap on 
the use of ATS in the region.
Europe. Amphetamine seizures in Europe continued 
their downward trend. A significant rise in seized 
clandestine amphetamine laboratories was observed. 
Methamphetamine use in Europe continues to ex-
pand. The European “ecstasy” market is on the 
rise as seizures more than doubled from 595 
kg in 2009 to 1.3 mt in 2010 and the MDMA 
content of ecstasy pills seems to increase. 
New psychoactive substances continue to 
emerge in the region and data on their use 
was reported from the UK and Spain. In April 
2012, Hungary adopted generic controls over 
new psychoactive substances and their manufac-
ture, distribution, importation and exportation.
Africa. Methamphetamine continues to be 
trafficked from African countries, particularly from 
West Africa to East and South-East Asia. Seizures 
started to increase in West Africa in 2008, with 
methamphetamine being smuggled into countries 
such as Japan and the Republic of Korea. Most illicit 
ATS laboratories are reported from South Africa, 
but two methamphetamine laboratories have been 
dismantled in Nigeria. The lack of adequate 
law enforcement capacity, infrastructure and 
appropriate legislation hampers the efforts 
of governments in the region to properly 
address the activities of drug trafficking 
organizations.
North America. North America accounted 
for approximately half of global methamphetamine 
seizures in 2010 with 22 mt compared to 13.7 mt in 
2009. The largest increase of seizures was reported 
by Mexico where seizures doubled to almost 13 mt. 
The United States reported a 1 mt increase in meth-
amphetamine seizures as well as higher average pu-
rity levels of methamphetamine and declining prices. 
Furthermore, seizures of unscheduled chemicals 
frequently used in the illicit manufacture of meth-
amphetamine are rising. With regard to new psycho-
active substances, legislation adding numerous 
substances to Schedule I of the Controlled 
Substances Act was enacted in July 2012. 
Central and South America. Increased sei-
zures of ATS precursors have been reported 
from countries such as Argentina, Belize and 
Guatemala. Illicit manufacture of metham-
phetamine has been reported, mainly from Gua-
temala, where two laboratories were dismantled. To 
counteract precursor diversions, Uruguay enacted 
legislation controlling pharmaceutical preparations 
containing pseudoephedrine and ephedrine. The use 
of ATS has been reported from many countries in the 
region, most recently from Argentina, due to the fo-
cus on traditional plant based drugs such as cocaine, 
the true ATS situation may be underreported. 
Regional overviews
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facture and marketing of mephedrone is controlled in 
the European Union and in Switzerland. Some other 
countries have also taken action to prevent the distri-
bution of mephedrone. 
4. Synthetic cannabinoids
Synthetic cannabinoid receptor agonists, e.g. JWH-
018 and JWH-122 mimic the effects of tetrahy-
drocannabinol (THC) found in cannabis and 
are frequently sold on the internet and in 
specialized shops as a smoking mixture. 
They first appeared on the drug market in 
2007 and became very popular among young 
adults and teenagers in Europe and the United 
States in a very short time. 
5. Plant-based substances: Khat, Kratom  
and Salvia divinorum
Khat (Catha edulis) is the most widespread plant-
based NPS and mainly grows in Eastern Africa. The 
main psychoactive ingredients in khat are stimulants 
cathine and cathinone, which are structurally similar 
to amphetamine and controlled by the 1971 Conven-
tion. The khat plant itself is not controlled. In  2010, 
533 mt were seized (see Figure 2). Kratom (Mitragyna 
speciosa) is a plant indigenous to South-East Asia, 
containing the alkaloid mitragynine. It is controlled 
in a number of countries, including Australia, Bhutan, 
Denmark, Malaysia, Myanmar, Lithuania and Thai-
land. In 2010, 24 mt were seized. Salvia divinorum is 
found in Latin America and is said to be the most po-
tent naturally-occurring psychedelic ever discovered, 
containing the Terpenoid Salvinorin A.  
Challenges of NPS
Although many of the psychoactive substances have 
been on the market for a long time the diversity of 
products has increased considerably, as manufactur-
ers  of NPS are very adaptive and flexible. The variety, 
the changing physical forms and constant modifica-
tions in labelling makes it difficult for law enforce-
ment and other authorities to identify NPS. Labora-
tories often do not have the analytical, forensic and 
toxicological capabilities. In addition, there are only 
a small number or no reference standards available 
which could help in the identification process. Often, 
the actual composition of NPS are unknown to us-
ers as well as to health workers or law enforcement 
officers. The listed contents on the package do not 
always match the active ingredients present and ge-
neric terms are used. 
The Internet is being increasingly used to facilitate 
distribution of these substances to a global au-
dience. The EMCDDA has noted a steady in-
crease in the number of online shops selling 
NPS: from 170 in 2010, to 314 in 2011 and 
690 in 2012. 
Global NPS monitoring
While several countries have set up national 
monitoring systems - e.g. Australia has established 
the Ecstasy and related Drugs Reporting System, Eu-
rope is the only region in the world where a regional 
Early Warning System has been set up which is man-
aged by the EMCDDA. 
Participating drug testing laboratories of the UNODC 
International Collaborative Exercises (ICE), report reg-
ularly on new psychoactive substances. In 2011, 42 per 
cent of 128 laboratories (48 countries) reported NPS. 
Synthetic cathinones were mostly found, followed by 
synthetic cannabinoids (Figure 3). The emergence of 
piperazines appeared to be declining in 2011. 
The importance of monitoring, analysing and report-
ing emerging trends in the composition, manufac-
ture, distribution and patterns of use of NPS is crucial. 
Collection and subsequent sharing of NPS-related in-
formation will substantially improve the capacity to 
detect and monitor new trends of NPS which in turn 
can contribute to preventing the rapid expansion of 
the problem. Further possible health and social im-
plications can be assessed and evidence based treat-
ment can be pursued. In addition, effective policy and 
programme interventions aimed at reducing both 
supply and demand can be designed. A global early 
warning system, with updates and alerts might be 
one approach to address this issue. 
Figure 3: Summary of NPS reported through the  
ICE portal 2010-2011 
 
 
Source: UNODC Delta
New psychoactive substances (NPS) were one of the 
key issues deliberated in March 2012, at the 55th 
session of the Commission on Narcotic Drugs. Broad 
global consensus on this topic led to the adoption of 
resolution 55/1 entitled “Promoting international 
cooperation in responding to the challenges 
posed by new psychoactive substances”. The 
resolution calls on Member States to moni-
tor emerging trends in the composition, 
production and distribution of new psycho-
active substances, patterns of use and share 
that information and adopt appropriate mea-
sures aimed at reducing supply and demand.  
What are NPS?
A NPS is a new narcotic or psychotropic drug, in pure 
form or in preparation, that is not controlled by the 
1961 United Nations Single Convention on Narcotic 
Drugs or the 1971 United Nations Convention on Psy-
chotropic Substances, but which may pose a public 
health threat comparable to that posed by substanc-
es listed in these conventions (European Monitor-
ing Centre on Drugs and Drug Addiction (EMCDDA)). 
The substances include synthetic compounds such as 
synthetic cannabinoids, synthetic cathinones, pipera-
zines, and the traditional plant-based psychoactive 
substances such as khat (Catha edulis), kratom (Mi-
tragyna speciosa) and Salvia divinorum.  
Some NPS have pharmacological properties and ef-
fects similar to controlled drugs such as cocaine, ec-
stasy and amphetamines and are therefore frequently 
marketed as “legal alternatives” to scheduled 
drugs. NPS are sold as “plant food”, “bath 
salts” or as “research chemicals”, in powder, 
tablet, capsule form or as smoking blends. 
Seizures of NPS have been made in all re-
gions of the world, including Australia and 
New Zealand, East and South-East Asia, Near 
and Middle East, Africa, Europe, North America 
and South America.
History
New drugs have always appeared on illicit drug mar-
kets (see Table 1). However, the pace at which such 
substances emerge has accelerated considerably. The 
significant increase of NPS in Europe can be seen from 
reports of the EMCDDA. Whereas, between 2000 and 
2005, on average five substances per year were re-
ported, from 2007 to 2010 about 150 NPS were identi-
fied through the EMCDDA Early Warning System. The 
highest number reported so far were 49 substances in 
2011, up from 41 substances in 2010 and just 24 
substances in 2009. 
An overview of NPS 
1. Ketamine
Ketamine is used as an anaesthetic in hu-
man and veterinary medicine and has been 
misused as a hallucinogen for almost 30 years. It 
is often sold as a liquid or whitish powder and as ‘ec-
stasy’ or ‘amphetamine’. Use has been reported from 
Asia, Americas, Europe and Oceania. The substance is 
controlled in many countries such as China, India and 
the United States. Overall seizures increased from 3.4 
mt in 2005 up to 11.7 mt in 2010 (see Figure 1), with 
several multi-ton seizures made in China, Canada and 
India.
2. Piperazines
Piperazines emerged first in Europe, New 
Zealand, Australia and spread slowly to 
countries in Asia and Latin America. The most 
commonly reported piperazine is benzylpipera-
zine (BZP), others include meta-Chlorophenylpipera-
zine (mCPP) and 3-Trifluoromethylphenylpiperazine 
(TFMPP). As central nervous stimulants piperazines 
have been sold as ‘ecstasy’ to meet demand from the 
illicit drug market. Many countries including Australia, 
Japan, New Zealand and all countries of the European 
Union have introduced national controls over BZP to 
prevent sale and distribution. 
3. Synthetic cathinones
Synthetic cathinones are analogues of the interna-
tionally controlled stimulant cathinone (one of the 
psychoactive substances in the khat plant), which are 
structurally related to amphetamine. 4-methylmeth-
cathinone (mephedrone) and methylenedioxypyrova-
lerone (MDPV) are the most commonly abused sub-
stances. Their use has been linked to fatalities in the 
European Union and also led to many emergency cas-
es in the United States. Since December 2010, manu-
The world’s new challenge: New Psychoactive Substances 
Table 1: New psychoactive substances through the years 
Year Chemical group Examples
1960 fentanyl α-methylfentanyl
phenethylamines DOM, MDMA 
1980 tryptamines DiPT, Foxy 
2000 piperazines BZP, mCPP, TFMPP, 2C-B
synth. cannabinoids JWH-018,-073,-200
synth. cathinones mephedrone, MDPV
Figure 1: Ketamine seizures, 2005-2010
 
Source: UNODC Delta
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Figure 2: Khat seizures, 2000-2010
 
Source: UNODC Delta
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 Regions covered in this issue
Note: The boundaries, names and designations used herein do not imply official endorsement or acceptance by the United Nations. 
Global SMART segments are arranged based on regional threat. Oceania has among the highest prevalence 
rates for ATS use in the world, while the number of ATS users are greatest in East Asia. Therefore, the map 
and corresponding index of segments begins with recent events from Oceania and East Asia and then moves 
geographically westward. The numbered pins on the map above correspond with the index of segments below.
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MANUKAU, New Zealand – 13 June 2012 1
SYDNEY, Australia – 30 July 2012 2
AUSTRALIA and CHINA – 27 June 2012 3
QUEENSLAND, Australia – June 2012 4
JAPAN – August 2012 5
JAKARTA, Indonesia – 3 May 2012 6
HONG KONG, China – 30 May 2012 7
HONG KONG, China – 30 May 2012 8
VIET NAM – 24 May 2012 9
SEPANG, Malaysia – 19 April 2012 10
THAILAND – 2 May 2012 11
PAKISTAN – 4 April 2012 12
HAMMAMET, Tunisia – 4 to 8 June 2012 13
LAGOS, Nigeria – 13 April 2012 14
COTONOU, Benin – 10 May 2012 15
BUDAPEST, Hungary – 2 April 2012 16
STOCKHOLM, Sweden – May 2012 17
BELGIUM – 31 May 2012 18
UNITED KINGDOM – 5 April 2012 19
UNITED KINGDOM – 14 March 2012 20
SCOTLAND, United Kingdom – March 2012 21
SPAIN – 26 April 2012 22
BRAZIL – 5 July 2012 23
URUGUAY – March 2012 24
SAN MIGUEL, Argentina – 26 & 27 April 2012 25
ARGENTINA – April 2012 26
SAN MARCOS and SANTA ROSA,  
Guatemala – 19 March & 5 April 2012
27
MEXICO – 13 May 2012 28
TORONTO, Canada – 13 May 2012 29
WASHINGTON D.C., United States – 9 July 2012 30
LOS ANGELES, United States – 19 April 2012 31
SAN JOSE, United States – 1 March 2012 32
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UNODC points to growth of amphetamine-type  
stimulants in West Africa 
3
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The United Nations Office on 
Drugs and Crime launched a 
new report on amphetamine-
type stimulants, the West Afri-
ca – 2012 ATS Situation Report 
in June 2012. The report focuses on 
the growing trend of synthetic drugs in West Africa 
specifically, and the African continent in general, and 
warns of an increase in the manufacture, trafficking 
and use of these illicit substances in recent years. The 
synthetic drugs available in the region are mostly am-
phetamine, methamphetamine, methcathinone and 
ecstasy-group substances. 
Historical background. For centuries, Africa has 
played a role in the global trade in both licit and il-
licit psychoactive substances, and heroin and cocaine 
have been trafficked through the region for more than 
a decade. Since 2006, there are indications that West 
African countries are being used as trans-shipment 
points for precursor chemicals 
such as ephedrine and pseudo-
ephedrine, the main chemicals 
used in the illicit manufacture 
of methamphetamine, from 
Asia. Since 2008, there have 
been an increasing number of 
reports of trafficking of meth-
amphetamine from West Af-
rica to Europe. 
Methamphetamine manu-
facture reported for the first 
time. Unlike cocaine or heroin, 
illicit ATS manufacture does 
not rely on the cultivation of 
naturally occurring plants such 
as coca or opium poppy, and 
as such, is not limited to cer-
tain geographic locations. This 
leaves the possibility that West 
Africa could be transformed 
not only into a key transit point 
in the trafficking of ATS, but has the potential to also 
become an ATS manufacturing hub. The first evidence 
of methamphetamine manufacture emerged from 
Nigeria in 2011 and in 2012, a second methamphet-
amine laboratory was dismantled by the Nigerian 
Drug Law Enforcement Agency.
Increased ATS trafficking to East and South-East 
Asia. Since 2008, cases of methamphetamine traffick-
ing from West African countries such as Benin, Côte 
d’Ivoire, Gambia, Ghana, Guinea, Mali, Nigeria and 
Senegal to countries in East and South-East Asia have 
been reported. Common destinations are Japan, Ma-
laysia, Republic of Korea and Thailand. Trafficking or-
ganizations target these markets due to the high price 
of methamphetamine. In Japan, for example, 1 kg of 
methamphetamine can be sold for at least 212,600 
USD. Outside the region, Australia and New Zealand 
have also reported the increasing role of West African 
organized crime groups in the trafficking of ATS and 
their precursors. Drugs are usually trafficked by air, in 
fairly small quantities (between 1 and 2 kg) but larger 
shipments have also been reported.
Precursor chemical diversions on the rise. Other parts 
of the region are also experiencing a rise in ATS-relat-
ed illicit activity. As governments have been strength-
ening controls over ephedrine and pseudoephedrine 
in recent years, there has been a shift in trafficking 
routes to Africa. In Kenya and the United Republic 
of Tanzania, authorities have reported rising thefts 
of methamphetamine precursors. In Kenya 21 thefts 
amounting to 2,253 kg were reported to the Phar-
macy and Poisons Board between September 2009 
and December 2011, which could have been used to 
manufacture over 1,500 kg methamphetamine. While 
there have been no reports of 
illicit ATS manufacture from the 
country, Kenyan couriers have 
been arrested with metham-
phetamine in South-East Asia. 
Such incidents provide indica-
tions on potential metham-
phetamine manufacture, which 
could be a future trend.
Lack of awareness. Assessing 
the true ATS situation in West 
Africa and Africa as a whole re-
mains difficult due to the per-
sistent lack of data from the 
region. Less than 20% of African 
countries and territories sub-
mit annual reports to UNODC 
and reported seizures of both 
ATS and their precursors are 
scarce. The present informa-
tion deficit on ATS in the region 
is principally due to a general 
lack of awareness of ATS, as law enforcement authori-
ties tend to focus on the interception of ‘traditional’ 
plant-based drugs. The lack of effective law enforce-
ment systems and border and precursor controls 
make West Africa an attractive location for the diver-
sion and trafficking of ATS and essential ATS precursor 
chemicals such as ephedrine and pseudoephedrine. 
Difficult economic and living conditions in many West 
African countries have led to further expanding the 
West African involvement in the heroin and cocaine 
drugs trade, which might also apply to the potential 
expansion of the illicit ATS trade in the region.
The report is available online at:  
http://www.unodc.org/documents/scientific/ATS_
West_Africa_final_2012.pdf
Indications of ATS manufacture in Africa 
since 2009
Source: Amphetamines and Ecstasy: 2011 Global ATS Assessment, Global 
SMART Programme, UNODC, September 2011.
Methamphetamine 
laboratories
Methcathinone 
laboratories
Possible ecstasy 
 manufacture
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Australia: record methamphetamine seizure (306 kg)
SYDNEY, Australia – 30 July 2012. 306 kg of crystalline methamphetamine and 252 kg of heroin with 
a market value of almost USD 524 million, were seized in Sydney during a joint operation by the 
Australian Federal Police (AFP) and Australian Customs and Border Protection Service. This marks 
the largest seizure of crystalline methamphetamine in AFP history (in 2010/11 404 kg of ATS were 
seized) and the third largest seizure of heroin. Four nationals from Hong Kong and three Australia-
based suspects were arrested. Investigations into the drug syndicate started in August 2011, follow-
ing information received from the Drug Enforcement Administration of the United States. On 19 
July 2012 two suspect cargo consignments with 3,200 terracotta pots were inspected by Customs 
and Border Protection officers at Port Botany (South-Eastern Sydney) and 100 of them were found 
to contain the drugs. The suspects have been charged with offences including smuggling and pos-
session of a commercial quantity of methamphetamine which carries a maximum penalty of life 
imprisonment.
 Joint Australian and Chinese operation dismantles drug syndicate 
AUSTRALIA and CHINA – 27 June 2012. The Australian Federal Police and the National Narcotics 
Control Commission of China have joined forces for the first time to dismantle an alleged transna-
tional drug trafficking organization. Authorities in Australia and China have seized a combined total 
of 3.35 mt of safrole-rich oil, containing 331 kg of safrole. A total of nine persons were arrested in 
connection with the seizure, six in China and three in Australia. This joint investigation started in 
April 2011 in Sydney, when Australian Customs and Border Protection officers detected three con-
signments of 2, 800 lt safrole oil hidden in a shipment of shampoo bottles (see segment 4 of Global 
SMART Update Vol.6). In September 2011, three men were charged in relation with this trafficking 
attempt. Further investigations by the National Control Commission of China resulted in seizures of 
500 kg safrole oil in March and April 2012. 
Wastewater analysis in Queensland shows increased 
methamphetamine and MDMA abuse on weekends 
QUEENSLAND, Australia – June 2012. Results of the first wastewater 
analysis conducted by the Australian Institute of Criminology show in-
creased use of methamphetamine and ecstasy during weekends. Sci-
entists estimate that on average 273 mg (2010) methamphetamine 
was used per 1000 people a day on weekends and 212 mg/day/1000 
during weekdays. Ecstasy use was estimated on average at 244 mg/
day/1000 on weekends and 100 mg/day/1000 on weekdays. In this 
study, wastewater was sampled at the inlet of a sewage treatment 
plant that receives water from a catchment in Queensland, with a population of over 150,000 peo-
ple. Samples were collected over a period of 12 days in November 2009 and over a period of 15 days 
in November 2010, to estimate daily methamphetamine, ecstasy and cocaine use. 
New Zealand: Control strategy targets street level  
dealing of methamphetamine 
MANUKAU, New Zealand – 13 June 2012. As a result of Operation 
Foiled of the New Zealand Police, 311 grams of methamphetamine 
with a street value of over USD 239,000 were seized in June 2012. Op-
eration Foiled is carried out by 50 police officers of Counties Manukau 
(South Auckland) Police and targets street level drug dealing across 
Manukau. Since the end of January to June 2012, a total of 412 grams 
of methamphetamine has been recovered.  The Operation was carried 
out in the context of the Government’s Methamphetamine Control 
Strategy, which was developed in 2009 and is designed to disrupt the supply of methamphetamine 
and reduce methamphetamine related crime. New Zealand Police work closely with partners like 
health agencies, and community groups to reduce the impact of drugs and crime.
Source: New Zealand Police
Japan: increased control of new psychoactive substances 
JAPAN – August 2012. The Japanese Health, Labor and Welfare Ministry has announced the desig-
nation of four synthetic substances - mephedrone, methylenedioxypyrovalerone (MDPV), JWH-018 
and cannabicyclohexanol – as ”narcotics” under the Pharmaceutical Affairs Law by August 2012. The 
new psychoactive substances, which are widely sold across Japan, will be made illegal and subjected 
to the same legal guidelines as traditional narcotics. The Ministry is also working on a regulation to 
regularly assess new psychoactive substances and re-designate their status where appropriate. This 
would help to ensure that new substances with slightly different chemical compositions but similar 
effects to controlled drugs, could be scheduled under the above regulation as well. Authorities in 
Japan have also reported a number of cases of people injuring others while driving under the influ-
ence of the new synthetic substances. 
Hong Kong: 412 kg of ketamine seized 
HONG KONG, China – 30 May 2012. More than 412 kg of ketamine 
with an estimated retail value of about USD 47 million, was seized by 
Hong Kong Customs from a river trade vessel arriving from Huangpu 
(Province Guangdong, South China) destined for Malaysia. A contain-
er declared to hold ‘ABS Resin’ contained ketamine in powder form, 
packed in 23 bags out of a total of 516 bags of goods. The seizure was 
made during a counter-narcotics operation at the main port facilities 
which aimed at disrupting transnational drug trafficking activities and 
strengthening the inspection of suspicious consignments transported 
by river trade vessels. A total of 70 containers were checked by Customs. Under the Dangerous 
Drugs Ordinance, drug trafficking carries a maximum penalty of life imprisonment and a fine of USD 
5 million.
Hong Kong Customs seizes 702 kg of pseudoephedrine 
in first five months of 2012
HONG KONG, China – 30 May 2012. Hong Kong Customs seized 
776,000 tablets of pseudoephedrine inside a cargo consignment 
which was declared as “Pepper Feeds” and imported from Singapore 
at Hong Kong International Airport. According to Customs, the chemi-
cal could have been used to manufacture about 6.6 kg of metham-
phetamine with a retail value of around USD 5.2 million. The tablets 
were destined for mainland China and were packed in aluminium foil 
bags covered by bags of pepper in eight carton boxes. From January 
to May 2012, customs officers intercepted six shipments of pseudoephedrine at Airport Cargo Ter-
minals and seized a total of about 702kg of pseudoephedrine tablets which could have been used in 
manufacturing 34 kg of methamphetamine worth over USD 26.5 million. 
Indonesia: 382,000 ecstasy pills and 30.5 kg crystalline methamphetamine 
seized 
JAKARTA, Indonesia – 3 May 2012. Jakarta Police seized 382,000 ecstasy pills and 30.5 kg of crystal-
line methamphetamine during drug raids which took place over two weeks in March and April 2012. 
The ecstasy pills had an estimated market value of USD 11.8 million and the crystalline metham-
phetamine was estimated at USD 4.7 million. Sixteen suspects were arrested in connection with the 
seizure. The drugs were trafficked in suitcases to Indonesia by sea using fishing boats. In total, more 
than 1 million ecstasy pills and 123 kg of crystalline methamphetamine were confiscated by the Ja-
karta Police between January to April 2012. Indonesia was formerly used as a transit country for ATS, 
but emerged during the past six years as a manufacturing location for crystalline methamphetamine 
and ecstasy, with significant seizures each year. In 2010 crystalline methamphetamine was reported 
to be the primary drug of use in Indonesia.* 
Source: Hong Kong Customs
Source: Hong Kong Customs
Source: Australian Institute of Criminology 
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More than one million methamphetamine pills seized in Thailand 
THAILAND – 2 May 2012. National police have seized more than one million methamphetamine pills 
with a street value of over USD 9.5 million and arrested two men with connections to many other 
drug trafficking organizations. Two suspects were arrested on charges of possessing illicit drugs and 
money laundering. Police found 100,000 methamphetamine pills inside the suspects’ car and a fur-
ther 920,000 in their house, wrapped in plastic packages. The house was being used as a warehouse 
and distribution point for drugs smuggled from Myanmar, then transported from Northern Thailand 
to Central Thailand before being sold nationwide. The trafficking group is believed to have connec-
tions to more than 100 drug networks. Twenty bank accounts were registered in their names and 
money from over 100 accounts had been transferred into their accounts. The suspects had allegedly 
been trafficking drugs for over a year.
Malaysia: customs seize ketamine in fake cashew nuts 
SEPANG, Malaysia – 19 April 2012. An attempt to smuggle ketamine 
inside fake cashew nuts was uncovered by the Kuala Lumpur Interna-
tional Airport’s Royal Malaysian Customs Department. Ketamine with 
a gross weight of 9.3 kg valued at USD 116,000 had been put into fake 
cashew nuts made from plastic, and packed together with genuine 
cashew nuts. An Indian national arriving from Chennai was detained 
after his bags were inspected and six packages of food containing the 
fake cashew nuts were found. The contents tested positive for ket-
amine, a substance not controlled by the international drug control 
treaties, but which is widely used in several countries in Asia and often sold as ‘ecstasy’ on these 
markets. Ketamine seizures in Malaysia were reported at 334 kg in 2010 and 1,071 kg in 2009.* 
ATS second most popular drug class used in Viet Nam 
VIET NAM – 24 May 2012. Amphetamine-type stimulants (ATS) such as meth-
amphetamine and ecstasy are the second most popular class of illicit drugs in 
Viet Nam after heroin, according to the report Amphetamine-type stimulants 
in Viet Nam, which was launched by UNODC in May 2012. The report highlights 
the rapid growth in drug use among young people many of which live in large 
cities, border areas and industrial zones. While ATS were predominantly sold in 
pill form prior to 2008, crystalline methamphetamine has now become more 
widespread. Methamphetamine pills are reportedly trafficked into the north of 
Viet Nam most commonly through the Laotian-Vietnamese border. Crystalline 
methamphetamine is reportedly trafficked mainly from Cambodia into south-
ern Viet Nam. 
Pakistan: Possible diversion of 9 mt of ephedrine
PAKISTAN – 4 April 2012. The Supreme Court in Pakistan is investigating a case of possible diversion 
of 9 mt of ephedrine, which was uncovered in October 2011. In 2010, two pharmaceutical compa-
nies obtained export quotas for ephedrine that exceeded the limits the government had reported to 
the International Narcotics Control Board by 9 mt. Allegedly only 150 kg were used in manufactur-
ing medicines while the rest went missing. Ephedrine is among the most frequently used starting 
materials in the illicit manufacture of methamphetamine. The 9 mt could have been used to manu-
facture around 6 mt of methamphetamine. Pakistan currently reports the fourth highest legitimate 
requirement for ephedrine in the world; behind China, the United States and the Republic of Korea. 
Countries with such high legitimate requirements can be attractive targets for precursor diversion.
Source: UNODC Viet Nam  
Country Office
Source: Bernama
Hungary: generic ban on new psychoactive substances 
BUDAPEST, Hungary – 2 April 2012. The Hungarian Government has issued generic controls over 
new psychoactive substances (NPS), effective from 2 April 2012. The Government decree (No. 
66/2012) introduced a new schedule for NPS, the so called List-C. It lists not only specific com-
pounds, but also groups of compounds in order to prevent attempts at chemical modifications to 
yield new chemicals not covered under the law. The Government has 12 months to make a risk as-
sessment of the substances on List-C and subsequently decide on either a permanent ban or lifting 
of the temporary ban. Manufacture, distribution, importation and exportation of these chemicals 
will be penalized by up to three years in prison. Possession and use are not criminalized. The legisla-
tion became necessary due to the rapidly growing trade in NPS and the constantly growing number 
of drug users requiring treatment. 
Benin: Nigerian businessman imprisoned for  
smuggling 5.3 kg methamphetamine
COTONOU, Benin – 10 May 2012. A Nigerian businessman was re-
portedly arrested with 5.3 kg methamphetamine in Benin by the Cen-
tral Office for Combating Illicit Trafficking in Drugs and Precursors. 
The country of origin of the methamphetamine was reported to be 
Nigeria, transiting Benin and were supposed to be further smuggled 
through Kenya (Nairobi) to its final destination Bangladesh (Dhaka). 
The suspect claimed having trafficked drugs through Benin several 
times before. According to the authorities, traffickers are changing 
their trafficking strategy and attempt to traffic drugs though freight services at the airport. The Gov-
ernment has made efforts to counteract increased drug trafficking by increasing the capacities of 
police and boarder control and strengthening the inspection of suspicious consignments. 
Nigeria: 25.4 kg of ephedrine concealed in sandals 
LAGOS, Nigeria – 13 April 2012. Officers of the National Drug Law En-
forcement Agency have foiled an attempt by a businessman to traffic 
25.4 kg ephedrine to Mozambique as unaccompanied cargo through 
the Murtala Mohammed International Airport in Lagos. The ephed-
rine, in powder form, was concealed inside the soles of 11 pairs of 
sandals. Ephedrine is a precursor chemical used in the manufacture 
of methamphetamine, but is also used for its stimulant effect. The 
seizure might indicate that the ephedrine was intended to be further 
smuggled to South Africa, where regionally, most illicit ATS laborato-
ries were dismantled. 
World Health Organization convenes 35th Expert Committee  
on Drug Dependence 
HAMMAMET, Tunisia – 4 to 8 June 2012. Substances including Gamma-hydroxybutyric acid, ket-
amine, 1-(3-chlorophenyl)piperazine (mCPP) and N-benzylpiperazine (BZP) were reviewed at the 
35th meeting of the Expert Committee on Drug Dependence (ECDD) of the World Health Organiza-
tion (WHO) which took place from 4 to 8 June 2012 in Hammamet, Tunisia. This was the first meet-
ing of the ECDD since 2006. The Expert Committee carried out a medical and scientific assessment 
of the dependence and abuse potential of a number of psychoactive substances, to guide WHO in its 
mandate with regard to changes in the scope of control of the Single Convention on Narcotic Drugs, 
1961, and the Convention on Psychotropic Substances, 1971. The results of the review are expected 
to be reported to the next session of the Commission on Narcotic Drugs, to be held in March 2013. 
Source: NDLEA 
Source: UNODC Regional Office West/ 
Central Africa
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UK bans methoxetamine 
UNITED KINGDOM – 5 April 2012. The UK Government has used a 
temporary ban on methoxetamine, also called ‘mexxy’ or MXE, fol-
lowing a recommendation from the Advisory Council on the Misuse of 
Drugs (ACMD). It is illegal to sell or supply methoxetamine, including 
giving it away to friends. Possession for personal use has not been 
criminalized, but police and border officials may search or detain any-
one suspected of having the drug and seize or destroy the controlled 
substance . The temporary order can last for up to 12 months to allow 
the ACMD to make a full assessment and advise the Government on 
whether the drug should be permanently banned. Those caught manufacturing, supplying or traf-
ficking the substance face up to 14 years in prison and an unlimited fine under the Misuse of Drugs 
Act 1971. 
Belgium: warning against 4-methylamphetamine (4-MA) 
BELGIUM – 31 May 2012. Experts warn against 4-methylamphetamine also known as 4-MA, which 
is suspected to have contributed to the deaths of at least five people in Belgium. The chemical was 
reported to the Belgian Early Warning System on drugs, which was established as a result of the 
adoption of the Joint Action on New Synthetic Drugs by the European Union in 1997. The onset ef-
fect of 4-MA is slower than that of amphetamine and the effects are believed to be similar to ecstasy 
and amphetamine. The substance was seized for the first time in 2009, and in August 2011 report-
edly led to a death in Belgium. According to the Austrian Check-it initiative which provides informa-
tion and free testing of synthetic substances to users, 4-MA was firstly registered in Austria in April 
2012. The drug was found to contain other substances such as amphetamine or ephedrine and was 
reportedly sold as “speed”. The drug has also appeared in Netherlands and the United Kingdom, 
where it has been associated with several fatalities. 
Amphetamines and ecstasy second most used drugs  
by European students 
STOCKHOLM, Sweden – May 2012. Three per cent of European students (15- 
to 16-year-olds) reported lifetime use with amphetamines and ecstasy, second 
only to cannabis (17 percent), finds the fifth ‘Substances use among students’ 
report of the European School Survey Project on Alcohol and Other Drugs. Ten 
out of 36 countries reported amphetamine lifetime use rates above the 3 per 
cent average including Bulgaria with 7 per cent, Hungary with 6 per cent and 
Belgium and Liechtenstein with 5 per cent. With regards to ecstasy, the high-
est country specific use rates were at 4 per cent found in eight countries, such 
as Albania, Bulgaria, Belgium, Latvia and Monaco. More than 100,000 students from 36 different 
European countries took part in the survey. Data was collected by group-administered anonymous 
questionnaires.
Ecstasy is the most widely used ATS, according to Guardian/Mixmag survey 
UNITED KINGDOM – 14 March 2012. Ecstasy (34 per cent) was found to be the fourth most widely 
used drug after alcohol and tobacco (92 per cent) and cannabis (53 per cent), according to the Guard-
ian/Mixmag drugs survey, one of the largest assessments of current drug use ever conducted. Over 
15,500 drug users (mainly from the UK and the US) responded to the drugs survey carried out online 
in November 2011. Data provided includes use patterns and trends, effects and quality of drugs and 
their health implications. The survey also provides an insight on new psychoactive substances with 
20 per cent indicating to have bought them in 2011. Only 19.5 per cent of UK users reported the use 
of mephedrone, since it was banned by the British government in 2010, compared to 51 per cent 
the year before. Synthetic cannabinoids were rated as more harmful than natural cannabis, with a 
2.5 per cent of users reporting that they had sought emergency medical help after using the drug. 
20
Source: UK Home Office
Uruguay: increase control of pharmaceutical prepara-
tions containing pseudoephedrine and ephedrine
URUGUAY – March 2012. A new decree entered into force by the 
Ministry of Health of Uruguay providing controls on the sale of phar-
maceutical preparations containing ephedrine and pseudoephedrine 
in order to prevent diversions onto the illicit drug market. Traffickers 
currently divert large amounts of both drugs in bulk and pharmaceuti-
cal preparation for the synthesis of methamphetamine. The decree 
ensures that the use of these substances are limited to scientific and 
medical purposes. Import and export authorizations are required for 
ephedrine and pseudoephedrine and will be issued by the health authority in Uruguay. Prior in-
formation on the need for importing and exporting those substances or pharmaceutical products 
containing those substances is needed by the health authorities. 
Study on use of new psychoactive substance conducted in Spain
SPAIN – 26 April 2012. Users of new psychoactive substances (NPS) in Spain are polydrug users 
according to a study conducted by the Hospital del Mar Research Institute-IMIM-UAB (Barcelona) 
Spain, the Energy Control (Barcelona) and Puerta Bonita Health Center (Madrid). The cross-sectional 
structured survey was included in specific drug forums on the internet with a total of 228 Spanish 
NPS users participating. The most frequently used substances were 2-CB (4-bromo-2,5-dimethoxy-
phenethylamine) (79.8 per cent), methylone (40.8 per cent), 2-CI (2,5-dimethoxy-4-iodophenethyl-
amine) (39.5 per cent) and mephedrone (35.5 per cent). NPS were frequently combined with other 
drugs such as cannabis (70.2 per cent) and ethanol (66.2 per cent). Most of them obtained NPS from 
friends (79.4 per cent) and the internet (41.7 per cent). Respondents (88.6 per cent) stated that 
they usually search the internet to obtain more information on the various NPS. This is one of a few 
studies on the use of NPS. 
Brazil: Federal Police records largest seizure of 
synthetic drugs 
BRAZIL – 5 July 2012. The Federal Police seized more than 74,000 ec-
stasy pills smuggled from Portugal, on two different occasions. Some 
28,000 ecstasy pills were seized at the International Airport of Guarul-
hos - Sao Paolo, leading to the arrest of a Brazilian national, only days 
after a seizure of 46,000 ecstasy pills at Rio de Janeiro International 
Airport also arriving from Portugal (Lisbon). Following a search by the 
Federal Police, two blocks of ecstasy, 10,000 points of LSD and can-
nabis were seized in the apartment of the three suspects. This repre-
sents the largest seizure of synthetic drugs ever made by the Federal Police at Rio de Janeiro Inter-
national Airport. The arrestees were charged with international drug trafficking and face a penalty 
of 5 to 25 years imprisonment.
Scotland: life-time prevalence of ATS second only to cannabis
SCOTLAND, United Kingdom – March 2012. Amphetamines (7.8 per cent) and 
ecstasy (7.2 per cent) were identified as the second and third most reported 
types of drugs ever used, according to the ‘Scottish Crime and Justice Survey 
2010/11 – Drug use’. Only rates for cannabis were higher. The survey identifies 
the extent of self-reported illicit life time drug use, drug prevalence in the last 
year and last month and the experience of first drug use of adults aged 16 or 
over. Around 11.000 participants took part in in-home, face-to-face interviews, 
which are conducted annually measuring people’s experience and perceptions 
of crime in Scotland. In 2010/11, fewer adults reported that they had used 
ecstasy in the last year (1.4 per cent) compared with 2009/10 (1.9 per cent) and 2008/09 (1.8 per 
cent). More than half (52.5 per cent) of the respondents reported using their drug of choice to-
gether with ecstasy. 
Source: Policia Federal Brazil
Source: California Dept. of Justice, Bureau of 
Narcotics Enforcement 
Source: ESPAD Source: The Scottish Government
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Argentina increases efforts to prevent diversion of ATS precursors 
SAN MIGUEL, Argentina – 26 & 27 April 2012. The first national meeting on chemical precursors 
organized by the Federal Drug Council of Argentina, in cooperation with the Secretariat for the Pre-
vention of Drug Addiction and the Fight against Drug Trafficking, marks the effort by Argentina to 
actively fight the problem of the expanding amphetamine-type stimulants market in the country. 
The meeting was aimed at members of the judiciary, public prosecutors, security forces, police as 
well as provincial and national institutions involved in the fight against illicit drugs. The increasing 
complexity of the market for precursor chemicals and the dynamics that impact the development 
of the national and regional chemical industry have led Argentina to strengthen controls to prevent 
possible diversion of substances, materials and precursors into illicit channels. 
Ecstasy use in combination with alcohol - a rising trend in Argentina
ARGENTINA – April 2012. Over 65 per cent of students (0.7 per cent  of a total of 90,450) in Argen- 
tina have used ecstasy in combination  with alcohol during the month preceding, informs  the latest 
study on drug abuse carried out by the Argentine Drugs Observatory. The study is conducted every 
2 years to estimate the  extent  of psychoactive substance abuse in adolescents between  13 and 17.  
Since 2011, lifetime  prevalence of  ecstasy has been increasing  from 0.2 per cent to 1.2 per cent in 
2005, to 2.1 per cent in 2007 and 2.6 per cent in 2009. The life time prevalence of ecstasy decreased 
significantly   in 2011 and  now stands at 2.1 per cent. The study also  examined several  risk  factors  
such as school, family and social background that are associated with drug use and the perception of 
students about theirlives and their environment, which are essential in designing effective policies. 
Guatemala: two ATS laboratories dismantled 
SAN MARCOS and SANTA ROSA, Guatemala – 19 March & 5 April 
2012. Two clandestine laboratories manufacturing amphetamine-
type stimulants were dismantled during two different operations in 
East and South Guatemala. In March, a methamphetamine laboratory 
was dismantled by the General Counternarcotics Directorate in coor-
dination with the Public Ministry, in the village Sisiltepeque, Catarina, 
San Marcos (East Guatemala). Authorities found six plastic barrels that 
contained approximately 50 kg of a yellow solid, believed to be an in-
termediate product of methamphetamine. The second laboratory was 
uncovered in Taxisco, Santa Rosa (South Guatemala) leading to the arrest of a Mexican and a Guate-
malan national. Quantities of sodium hydroxide and tartaric acid were also found in the laboratory. 
More than 146 mt of chemical precursors seized in 
West Mexico 
MEXICO – 13 May 2012. A joint action by the Tax Administration Ser-
vice, the Secretariat of the Navy of Mexico and the Attorney Gener-
al’s Office led to a total seizure of 130 mt of monomethylamine and 
phenylmethyl acetate, chemicals used in the manufacture of meth-
amphetamine. The seven containers arrived at the port of Lazaro 
Cardenas, Michoacan (West Mexico), from China and were bound for 
Honduras. No arrests were made in connection with the precursor 
chemical seizure. This marks the first attempt in 2012, of precursors 
being trafficked from Mexico to Honduras. On 17 June another 16 mt seizure of the chemical precur-
sor methylamine was made at the port of Manzanillo, Colima (West Mexico) onboard a ship from 
the Republic of Korea. The containers stored about 640 bags of 25 kg each. 
Source: SEMAR
Source: Policia Nacional Civil Guatemala
US: President signs legislation that bans new psychoactive substances 
WASHINGTON D.C., United States – 9 July 2012. President Obama signed new legislation banning 
the sale of new psychoactive substances. Numerous chemicals, including MDPV (methylenedioxypy-
rovalerone) and mephedrone (4-methylmethcathinone) were added to Schedule I of the Controlled 
Substances Act, which lists drugs that are illegal and cannot be prescribed under any circumstances. 
The ban prohibits the sale of those chemicals in local and online shops. In addition, not only the 
compounds currently identified as new psychoactive substances are banned, but also analogues and 
mimetics that may be produced in the future are outlawed, creating criteria by which similar chemi-
cal compounds are controlled. The Senate passed synthetic drug control legislation in May 2012, 
after the House of Representatives had done so in December 2011 and the temporary emergency 
ban by the Drug Enforcement Administration in October 2011.
US: one of the largest domestic seizures of  
methamphetamine (341 kg)
SAN JOSE, United States – 1 March 2012. Some 341 kg of metham-
phetamine with a street value of USD 34 million was seized, making 
it one of the largest domestic methamphetamine seizures in history, 
according to the Drug Enforcement Administration. The seizure was 
made in the course of an investigation on a case involving stolen elec-
tronic goods. Detectives of the Palo Alto Police Department Investi-
gative Services Division discovered a large quantity of methamphet-
amine in an apartment in San Jose. A detailed investigation of the 
apartment revealed that it was being used as a methamphetamine conversion laboratory where 
methamphetamine was being converted to its crystalline form, “ice”. Three individuals were ar-
rested on state drug violations. All aspects of the investigation are ongoing. 
Some 2.5 tons of methylamine chloride seized in the US
LOS ANGELES, United States – 19 April 2012. U.S. Customs and Bor-
der Protection officers seized two shipments containing 2,591 kg of 
methylamine chloride which is used as a precursor for methamphet-
amine. The white powdery chemical was stored in 80 bags at an air 
cargo consignment facility of Los Angeles International Airport. The 
chemical could have been used to manufacture methamphetamine 
with a street value of USD 40 million. The shipments arrived from 
China on April 19 and 23 and were bound for Mexico. Methylamine 
chloride is controlled in the US and has many legitimate industrial ap-
plications in pesticides, solvents and pharmaceutical products. Suppliers of these products are sub-
ject to regulations and control measures regarding manufacture, importation, use and distribution.
Canada: study examines mortality among methamphetamine users 
TORONTO, Canada – 13 May 2012. Individuals with methamphetamine-use disorders have a high-
er mortality risk than those abusing cannabis, cocaine, or alcohol, but a lower mortality risk than 
persons with opioid-related disorders. This new study conducted by the Centre for Addiction and 
Mental Health in Toronto, Ontario Cancer Institute Biostatistics Group, the University of Toronto 
and University of Arizona (United States) is one of the first investigating the mortality rate of meth-
amphetamine users. Almost 830,000 individuals hospitalized in California from 1990 to 2005 with 
diagnoses of methamphetamine-, alcohol- , opioid-, cannabis-, or cocaine-related disorders were 
observed for up to 16 years. Age-, sex-, and race-adjusted standardized mortality rates were gen-
erated. Given the lack of long-term studies of mortality risk among individuals with drug related 
disorders, the current study provides important information for the assessment of the comparative 
drug-related burden associated with methamphetamine use. 
Source: US Customs and Border Protection
Source: Drug Enforcement Administration
Global SMART accomplishments for 2012
The Global SMART (Synthetics Monitoring: Analyses, Reporting and Trends) Programme improves the 
capacity of targeted Member States to generate, manage, analyze, report and use information on illicit 
synthetic drugs. The programme launched formal operations in September 2008 in Bangkok. 
Publications
• Global SMART Updates Volume 7 and 8 (English and Spanish);
• Illicit market for ATS, 2012 World Drug Report;
• West Africa – 2012 ATS Situation Report;
• Indonesia – 2012 ATS Situation Report (forthcoming).
Conferences and Meetings
• Side event on new psychoactive substances at the 55th session of the Commission on Narcotic 
Drugs, Vienna, Austria in March 2012; (co-organized with Australia)
• Fourth annual Global SMART Programme Advisory Group Meeting, Vienna, Austria in March 
2012;
• Fourth SMART annual regional synthetic drug information workshop in East and South-East 
Asia, in July 2012.
SMART disseminated information on ATS and new psychoactive substances at:
• Third Operational Working Group Meeting on Operation ICE TRAIL, Teheran, Iran (Islamic 
Republic of) in January 2012;
• Joint session of the Enforcement Committee and Technical Committee of the World Customs 
Organization, Brussels, Belgium in March 2012;
• 2012 NIDA International Forum - Second interdisciplinary forum on new and emerging 
psychoactive substances by the U.S. National Institute on Drug Abuse and EMCDDA, Palm 
Springs, United States in June 2012;
• International Forum on Building an Integrated System in Dealing Professionally with Chemical 
Precursors, Dubai, United Arab Emirates in June 2012.
UNODC would like to specifically recognize the following funding partners for their investment in the 
Global SMART Programme. UNODC would also like to acknowledge the significant contributions of our 
partner, the Inter-American Drug Abuse Control Commission (CICAD), for their support regarding this 
publication.
 
The Global SMART Programme is managed by the Laboratory and Scientific Section of the Division for Policy 
and Analysis and Public Affairs. UNODC reiterates its appreciation and gratitude to Members States and partner 
agencies for the reports and information that provided the basis of this report. 
If you have comments on this report, or would like to contribute information that should be considered for future 
reports, please contact the Global SMART Programme at globalsmart@unodc.org. Information on the Global 
SMART Programme can be found via the internet at www.unodc.org and www.apaic.org or by contacting UNODC 
at the Vienna International Centre, P.O. Box 500, A-1400, Vienna, Austria. 
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